Health Sciences Group, Inc.
HESG · OTC
12/31/2012 | 12/31/2005 | 12/31/2004 | 12/31/2003 | |
|---|---|---|---|---|
| Revenue | $358 | $60 | $67 | $5,365 |
| % Growth | 496% | -10.5% | -98.7% | – |
| Cost of Goods Sold | $333 | $37 | $21 | $4,367 |
| Gross Profit | $25 | $23 | $47 | $998 |
| % Margin | 7% | 38.1% | 69.4% | 18.6% |
| R&D Expenses | $0 | $61 | $7 | $50 |
| G&A Expenses | $0 | $5,532 | $4,388 | $0 |
| SG&A Expenses | $80 | $7,165 | $4,391 | $4,211 |
| Sales & Mktg Exp. | $0 | $1,633 | $3 | $0 |
| Other Operating Expenses | $0 | $279 | $196 | $541 |
| Operating Expenses | $80 | $7,505 | $4,594 | $4,802 |
| Operating Income | -$54 | -$7,482 | -$4,547 | -$3,803 |
| % Margin | -15.2% | -12,440.6% | -6,766% | -70.9% |
| Other Income/Exp. Net | $0 | $1,906 | -$896 | -$1,555 |
| Pre-Tax Income | -$54 | -$5,576 | -$5,444 | -$5,358 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$54 | -$5,750 | -$10,452 | -$7,419 |
| % Margin | -15.2% | -9,560.7% | -15,552.6% | -138.3% |
| EPS | -0.029 | -0.25 | -0.78 | -0.76 |
| % Growth | 88.4% | 67.9% | -2.6% | – |
| EPS Diluted | -0.029 | -0.25 | -0.78 | -0.76 |
| Weighted Avg Shares Out | 1,871 | 24,560 | 14,125 | 11,101 |
| Weighted Avg Shares Out Dil | 1,871 | 24,560 | 14,125 | 11,101 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $10 | $2,512 | $1,262 | $1,479 |
| EBITDA | -$45 | -$4,970 | -$3,285 | -$2,324 |
| % Margin | -12.5% | -8,263.8% | -4,888.1% | -43.3% |